Evidence map›Paper›PMID 36864136›Full record

ArticleNature human behaviour2023

Rare CNVs and phenome-wide profiling highlight brain structural divergence and phenotypical convergence.

Jakub Kopal, Kuldeep Kumar, Karin Saltoun, Claudia Modenato, Clara A Moreau, Sandra Martin-Brevet, Guillaume Huguet, Martineau Jean-Louis, Charles-Olivier Martin, Zohra Saci and 22 more

Open access · greenAbstract read
In one paragraph

Article in Nature human behaviour, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The pleiotropic spectrum of proximal 16p11.2 CNVs.American journal of human genetics · 2024
    Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 10 institutions in 8 countries.

Jakub KopalDepartment of Biomedical Engineering, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.ORCID 0000-0002-1201-2872
Kuldeep KumarCentre de recherche CHU Sainte-Justine and University of Montréal, Montréal, Quebec, Canada.ORCID 0000-0003-3313-135X
Karin SaltounDepartment of Biomedical Engineering, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.ORCID 0000-0003-0971-1266
Claudia ModenatoLREN - Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.
Clara A MoreauHuman Genetics and Cognitive Functions, CNRS UMR 3571: Genes, Synapses and Cognition, Institut Pasteur, Paris, France.
Sandra Martin-BrevetLREN - Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.
Guillaume HuguetCentre de recherche CHU Sainte-Justine and University of Montréal, Montréal, Quebec, Canada.ORCID 0000-0002-4746-6030
Martineau Jean-LouisCentre de recherche CHU Sainte-Justine and University of Montréal, Montréal, Quebec, Canada.ORCID 0000-0002-3305-3307
Charles-Olivier MartinCentre de recherche CHU Sainte-Justine and University of Montréal, Montréal, Quebec, Canada.
Zohra SaciCentre de recherche CHU Sainte-Justine and University of Montréal, Montréal, Quebec, Canada.ORCID 0000-0003-2788-1306
Nadine YounisCentre de recherche CHU Sainte-Justine and University of Montréal, Montréal, Quebec, Canada.
Petra TamerCentre de recherche CHU Sainte-Justine and University of Montréal, Montréal, Quebec, Canada.
Elise DouardCentre de recherche CHU Sainte-Justine and University of Montréal, Montréal, Quebec, Canada.ORCID 0000-0003-4205-8828
Anne M MaillardService des Troubles du Spectre de l'Autisme et apparentés, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.
Borja Rodriguez-HerrerosService des Troubles du Spectre de l'Autisme et apparentés, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.ORCID 0000-0001-9392-7996
Aurèlie PainService des Troubles du Spectre de l'Autisme et apparentés, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.
Sonia RichetinService des Troubles du Spectre de l'Autisme et apparentés, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.
Leila KushanSemel Institute for Neuroscience and Human Behavior, Departments of Psychiatry and Biobehavioral Sciences and Psychology, UCLA, Los Angeles, CA, USA.ORCID 0000-0002-2650-7147
Ana I SilvaSchool for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.ORCID 0000-0002-1184-4909
Marianne B M van den BreeMRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.ORCID 0000-0002-4426-3254
David E J LindenSchool for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.
Michael J OwenMRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.ORCID 0000-0003-4798-0862
Jeremy HallMRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
Sarah LippéCentre de recherche CHU Sainte-Justine and University of Montréal, Montréal, Quebec, Canada.
Bogdan DraganskiLREN - Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-5159-5919
Ida E SønderbyNORMENT, Division of Mental Health and Addiction, Oslo University Hospital and University of Oslo, Oslo, Norway.
Ole A AndreassenNORMENT, Division of Mental Health and Addiction, Oslo University Hospital and University of Oslo, Oslo, Norway.ORCID 0000-0002-4461-3568
David C GlahnDepartment of Psychiatry, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
Paul M ThompsonImaging Genetics Center, Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, Los Angeles, CA, USA.
Carrie E BeardenSemel Institute for Neuroscience and Human Behavior, Departments of Psychiatry and Biobehavioral Sciences and Psychology, UCLA, Los Angeles, CA, USA.ORCID 0000-0002-8516-923X
Sébastien JacquemontCentre de recherche CHU Sainte-Justine and University of Montréal, Montréal, Quebec, Canada.
Danilo BzdokDepartment of Biomedical Engineering, Faculty of Medicine, McGill University, Montreal, Quebec, Canada. danilobzdok@gmail.com.ORCID 0000-0003-3466-6620
Centre Hospitalier Universitaire Sainte-Justine · CAUniversity Hospital of Lausanne · CHCardiff University · GBMaastricht University · NLMila - Quebec Artificial Intelligence Institute · CAOslo University Hospital · NOBoston Children's Hospital · USCentre National de la Recherche Scientifique · FRImaging Center · USMontreal Neurological Institute and Hospital · CA

Funding

Training U54EB020403 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2014 to 2018
$10.1M
Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI Hisashi Umemori · 2021 to 2026
$9.4M
Neurodevelopment and Psychosis in the 22q11.2 Deletion SyndromeR01MH085953 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BEARDEN, CARRIE E · 2010 to 2020
$6.2M
Large-Scale Evaluation of the Effect of Rare Genetic Variants on Psychiatric Symptoms and Cognitive AbilityU01MH119690 · NIMH · BOSTON CHILDREN'S HOSPITAL · PI ALMASY, LAURA A., GLAHN, DAVID C · 2019 to 2023
$5.9M
Integrative Molecular and Phenotype Analysis of 22q11.2 Deletion SyndromeR01MH100900 · NIMH · STANFORD UNIVERSITY · PI HALLMAYER, JOACHIM F · 2013 to 2017
$4.8M
Neurodevelopment and Psychosis in the 22q11.2 Copy Number VariantsR37MH085953 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CARRIE E BEARDEN · 2023 to 2026
$2.9M
Understanding Rare Genetic Variation and Disease Risk: A Global Neurogenetics InitiativeR01MH129858 · NIMH · SAINTE-JUSTINE UNIVERSITY HOSPITAL CTR · PI CARRIE E BEARDEN, Sebastien Jacquemont · 2023 to 2026
$2.4M
Investigating the impact of loneliness on brain aging and pre-symptomatic Alzheimer's disease progressionR01AG068563 · NIA · MCGILL UNIVERSITY · PI BZDOK, DANILO, SPRENG, ROBERT NATHAN · 2020 to 2024
$2.3M
Application of a Bayesian strategy to ABCD: Identification of substance use risk and COVID-19 effects on neurodevelopmentR01DA053301 · NIDA · YALE UNIVERSITY · PI Sarah Yip · 2022 to 2026
$1.6M
6/9: Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders.U01MH119739 · NIMH · SAINTE-JUSTINE UNIVERSITY HOSPITAL CTR · PI JACQUEMONT, SEBASTIEN · 2020 to 2024
$527k
Integration of Five Large-Scale Neuropsychiatric Genetic Datasets under the RDoC FrameworkR03MH105808 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BEARDEN, CARRIE E, FEARS, SCOTT C. · 2015 to 2016
$154k
Medical Research Council MC_PC_17212Medical Research Council MR/L010305/1Medical Research Council MR/W028395/1NIA NIH HHS R01 AG068563NIBIB NIH HHS U54 EB020403NICHD NIH HHS P50 HD105351NIDA NIH HHS R01 DA053301NIMH NIH HHS R01 MH085953NIMH NIH HHS R01 MH100900NIMH NIH HHS R01 MH129858NIMH NIH HHS R03 MH105808NIMH NIH HHS R37 MH085953NIMH NIH HHS U01 MH119739Wellcome Trust 100202
6 · The paper itself

Abstract

Copy number variations (CNVs) are rare genomic deletions and duplications that can affect brain and behaviour. Previous reports of CNV pleiotropy imply that they converge on shared mechanisms at some level of pathway cascades, from genes to large-scale neural circuits to the phenome. However, existing studies have primarily examined single CNV loci in small clinical cohorts. It remains unknown, for example, how distinct CNVs escalate vulnerability for the same developmental and psychiatric disorders. Here we quantitatively dissect the associations between brain organization and behavioural differentiation across 8 key CNVs. In 534 CNV carriers, we explored CNV-specific brain morphology patterns. CNVs were characteristic of disparate morphological changes involving multiple large-scale networks. We extensively annotated these CNV-associated patterns with ~1,000 lifestyle indicators through the UK Biobank resource. The resulting phenotypic profiles largely overlap and have body-wide implications, including the cardiovascular, endocrine, skeletal and nervous systems. Our population-level investigation established brain structural divergences and phenotypical convergences of CNVs, with direct relevance to major brain disorders.

Indexed as

BrainDNA Copy Number VariationsHumans

Identifiers

PMID36864136
PMCPMC7615290
OpenAlexW4322766075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.